Recherche et médias

Résultats révolutionnaires

Nous nous concentrons continuellement sur la recherche et l’innovation. Découvrez nos dernières découvertes et perspectives ci-dessous.


Webinars

Noninvasive Assessment of NAFLD/NASH

2020 Presentation by Raza Malik, M.D., Ph.D.

VISIONNER LA VIDÉO >

Watch the video

Noninvasive Assessment of NAFLD/NASH

2020 Presentation by Raza Malik, M.D., Ph.D.

AASLD 2019

Presentation by Raza Malik, M.D., Ph.D.

VISIONNER LA VIDÉO >

Watch the video

AASLD 2019

Presentation by Raza Malik, M.D., Ph.D.

Sign up for our upcoming webinars and events.


Médias

Boost in fight against liver disease

Read more >

Read more

Early Detection of Liver Disease

Francois Michelon, CEO of ENDRA Life Sciences Inc., explains how ENDRA is leading early detection of liver diseases and issues with existing tools’ diagnostic and accessibility properties.

VISIONNER LA VIDÉO >

Watch the video

Early Detection of Liver Disease

Francois Michelon, CEO of ENDRA Life Sciences Inc., explains how ENDRA is leading early detection of liver diseases and issues with existing tools’ diagnostic and accessibility properties.

Childhood Obesity and Liver Disease

Francois Michelon, CEO of ENDRA Life Sciences Inc., discusses childhood obesity and the risks of NAFLD.

VISIONNER LA VIDÉO >

Watch the video

Childhood Obesity and Liver Disease

Francois Michelon, CEO of ENDRA Life Sciences Inc., discusses childhood obesity and the risks of NAFLD.

World Hepatitis Day 2020

Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ technology can help detect and monitor NAFLD-NASH caused by hepatitis.

VISIONNER LA VIDÉO >

Watch the video

World Hepatitis Day 2020

Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ technology can help detect and monitor NAFLD-NASH caused by hepatitis.

Here + Now: Broadening Access to Healthcare

Renaud Maloberti, CCO of ENDRA Life Sciences Inc., talks about the importance of early diagnosis and access to healthcare.

VISIONNER LA VIDÉO >

Watch the video

Here + Now: Broadening Access to Healthcare

Renaud Maloberti, CCO of ENDRA Life Sciences Inc., talks about the importance of early diagnosis and access to healthcare.

Liver Disease and TAEUS®

Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ is focused on early detection of liver disease by measuring liver fat.

VISIONNER LA VIDÉO >

Watch the video

Liver Disease and TAEUS®

Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ is focused on early detection of liver disease by measuring liver fat.

CE Mark and Commercialization

Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about the significance of CE Mark certification.

VISIONNER LA VIDÉO >

Watch the video

CE Mark and Commercialization

Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about the significance of CE Mark certification.

Endra Life Sciences

Politique ENDRA concernant le parrainage de la recherche

ENDRA Life Sciences participe activement aux collaborations de recherche externes avec des organismes de recherche universitaires et privés. La politique de ENDRA Life Sciences vise à limiter à 15 % le montant des coûts indirects associés à tout financement qu’elle fournit à tout organisme de recherche, par le biais d’accords de parrainage de recherche, d’accords de recherche collaborative ou d’autres accords liés à la recherche.

ENDRA ne prendra pas en charge les frais généraux, coûts indirects ou autres coûts associés à la recherche qui dépasse quinze pour cent (15 %) du montant de recherche stipulé dans le contrat.

Voir plus. Faire plus. Vivre mieux.

CONTACTER ENDRA >